Why Treating PMOS Like an Ovary Problem Has Been the Wrong Approach All Along
- 2 days ago
- 3 min read
By Carrie Lam, MD, FAAMFM, ABAARM
For most of my career, I have watched women walk into clinics with the same story. Irregular cycles. Unexplained weight gain. Fatigue that does not improve with rest. Skin that breaks out no matter what they do.
They get an ultrasound, they get a diagnosis, and they get sent home with a prescription. And for years, that was considered a complete workup.
It was not complete. Not even close.
The recent rename of PCOS to polyendocrine metabolic ovarian syndrome, or PMOS, is one of the most significant shifts in women's health in decades. Not because the condition changed. It did not.
But because the name we used to describe it was quietly shaping how every physician in every specialty approached it, and that approach was missing the bigger picture entirely.
I know this because I lived it myself.
Six years ago, while building Lam Clinic, I was also quietly managing my own PMOS without knowing what to call it. I was doing everything a physician is supposed to do.
I was seeing the right specialists, following the right protocols, and getting nowhere. My cycles were irregular, my body was not responding, and every standard marker came back looking acceptable on paper.
The problem was that I was asking the wrong question. I kept asking how to fix my ovaries. I should have been asking why my entire endocrine and metabolic system was under stress in the first place.
That distinction is everything.
PMOS is not a reproductive condition with metabolic side effects. It is a multi-system hormonal and metabolic condition that happens to affect reproductive function.
The endocrine disruption comes first. The ovarian symptoms are downstream.
When we treat only what we can see on an ultrasound, we are not treating the condition.
We are treating one consequence of it while the underlying dysfunction continues unchecked.
When I finally ran a full workup on myself, not just the standard reproductive panel but a four-point cortisol curve, a detailed micronutrient screen, and a thorough look at insulin sensitivity, the picture became clear immediately.
My cortisol was dysregulated. My nutrient stores were depleted. My body was operating in a state of chronic physiological stress that no amount of cycle-regulating medication was ever going to resolve.
Research consistently shows that women with PMOS carry significantly higher baseline cortisol levels than women without the condition. That is not incidental.
Cortisol directly suppresses the hormones involved in ovulation. It drives insulin resistance. It depletes the micronutrients, particularly magnesium, zinc, and inositol, that are essential for healthy hormone production.
The stress axis is not a background variable in PMOS. It is a central driver.
Once I addressed those root causes, my body responded in a way it never had under conventional treatment. My cycles regulated within four months. The symptoms that had felt permanent began to resolve.
I was not lucky. I was finally asking the right questions.
The rename to PMOS matters because language shapes clinical behavior. When the name says ovary, the treatment targets the ovary.
When the name says polyendocrine metabolic, it opens the door to a fundamentally different kind of workup, one that includes cortisol patterns, insulin sensitivity, nutrient status, gut health, and the psychological burden that the new clinical definition now explicitly recognizes as part of the condition itself.
For the women reading this who have been told their labs are normal while their bodies are clearly telling them otherwise, the rename is a formal validation of what you already knew. You were not overreacting.
You were under-investigated.
Symptoms are information. Irregular cycles, skin changes, fatigue, mood disruption, none of these are random.
They are the body pointing at something upstream, and the most important clinical skill we can develop is the willingness to follow that signal all the way back to its source.
That is the shift PMOS demands. And it is long overdue.
Connect With Carrie
Comments